Npy Y4 Agonist as Therapeutic Agent for Disease Accompanied by Intestinal Tract Dysfunction

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090029406A1
SERIAL NO

12223573

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention has its object to provide an agent capable of ameliorating the intestinal tract dysfunction through a novel mechanism of action. It also has its object to provide a method for the evaluation of a compound, including the screening of the agent. A disease accompanied by intestinal tract dysfunction can be ameliorated or treated by using an NPY Y4 agonist as a therapeutic agent. A compound capable of ameliorating or treating a disease accompanied by intestinal tract dysfunction can be evaluated or screened by evaluating a compound targeting to an NPY Y4 receptor.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BANYU PHARMACEUTICAL CO LTDCHUO-KU TOKYO

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hirose, Hiroyasu Ibaraki , JP 2 0
Kanatani, Akio Ibaraki , JP 54 583
Kanno, Tetsuya Ibaraki , JP 6 7
Moriya, Ryuichi Ibaraki , JP 11 40
Suzuki, Jun Ibaraki , JP 326 4161

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation